|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 482.42 USD | +1.85% |
|
+1.95% | -0.99% |
EPS & Dividend: United Therapeutics Corporation
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 11.54 | 10.06 | 15 | 19.81 | 24.64 | 26.97 | 28.58 | 30.74 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Reference price 2 | 151.79 | 216.08 | 278.09 | 219.89 | 352.84 | 482.42 | 482.42 | 482.42 |
| Nbr of stocks (in thousands) | 44,441 | 45,037 | 45,577 | 46,994 | 44,645 | 43,057 | 43,057 | - |
| Announcement Date | 2/24/21 | 2/24/22 | 2/22/23 | 2/21/24 | 2/26/25 | - | - | - |
1USD in Million2USD
Estimates
Upcoming events: United Therapeutics Corporation
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | 17.88x | 2.57x | 5.53x | |
| 0.64% | 0.71% | 31.01x | 18.94x | 11.75x | |
| 2.18% | 2.3% | 24.77x | 6.7x | 6.01x | |
| 2.81% | 2.98% | 65.02x | 22304.6x | 7.68x | |
| 2.72% | 2.8% | 19.35x | 6.82x | 4.81x | |
| 1.55% | 1.59% | 33.11x | 7.3x | 5.93x | |
| 2.65% | 2.73% | 21.99x | 6.72x | 6.1x | |
| 2.66% | 2.76% | 15.7x | 5.48x | 5.03x | |
| 3.51% | 3.69% | 14.77x | 6.35x | 5.12x | |
| 2.69% | 2.87% | 25.23x | 16.68x | 6.36x | |
| Average | 2.14% | 2.24% | 26.88x | 2,238.22x | 6.43x | |
| Weighted average by Cap. | 2.04% | 2.14% | 29.42x | 2,497.19x | 7.40x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition